France-based SURGAR specializes in AR solutions for minimally invasive surgery. The company's software merges a patient's digital twin, obtained through MRI or CT scans, alongside the laparoscopic view in real time. This technology allows surgeons to visualize internal organ structures such as tumors, vessels, and ducts during procedures. SURGAR aims to halve surgical complications and increase precision by 20x.
SURGAR's product line includes “U-SURGAR,” a software dedicated to treating fibroids and adenomyosis in female patients, as well as “L-SURGAR” and “K-SURGAR,” aimed at treating liver and kidney cancers, respectively. The company is also developing other AI-driven applications, including those for endometriosis. The use of SURGAR's technology has been shown to reduce surgical complications by half, decrease morbidity by 10%, and improve precision by 20% while enhancing patient comfort.
Key customers and partnerships
In June 2024, the company partnered with the University Hospital of Grenoble Alpes to consolidate a unique database of surgical videos.
Competitors: None under coverage in the same geographic scope (SURGAR provides AR surgical guidance solutions specifically for healthcare providers in France)
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.